|
Welcome to Santen’s news page. Here you’ll find a list of current press releases covering a variety of Santen announcements, achievements, and updates—all of which can be downloaded in PDF format.
|
2011 |
 |
Nov, 2011
Emeryville, CA
|
Santen Announces FDA Orphan Drug Status for Sirolimus (DE--109) .
[pdf: 58KB]
|
Sept, 2011
Emeryville, CA
|
Santen Announces EMA Orphan Drug Status For Sirolimus (DE-109) .
[pdf: 72KB]
|
July, 2011
Emeryville, CA
|
Santen Inc., a wholly owned subsidiary of Santen Pharmaceuticals Co., Ltd. of Osaka, Japan, announced the addition of four new employees to the Global Clinical and Medical Affairs Group.
[pdf: 99KB]
|
June, 2011
Napa, CA
|
Santen announces the initiation of a multinational Phase III Program evaluating sirolimus (DE-109) for the treatment of non infectious posterior uveitis
[pdf:118KB]
|
Apr, 2011
Napa, CA
|
Santen Inc. Announces Relocation of U.S. Corporate Headquarters [pdf:60KB]
|
|
Back to top
|
|
|
